Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
The design, synthesis, and in vitro activity of a series of novel 5-ethynyl-2-aryloxybenzylamine-based histamine H(3) ligands that are also serotonin reuptake transporters is described.